n a microscopic particle of triglycerides produced in the intestines during digestion; in the bloodstream they release their fatty acids into the blood
Isis Reports Final Phase 2 Data on ISIS-APOCIII Rx in Patients With Familial Chylomicronemia CARLSBAD, Calif., May 2, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced the final data from its Phase 2 study of ISIS-APOCIIIRx as a monotherapy in patients with familial chylomicronemia syndrome, or FCS. In this open-label study, three patients with...
May 2, 2014 - PR Newswire